Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants
Clinical trial NCT00937404 · COMPLETED
Trial details
- NCT number
- NCT00937404
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-04
- Primary completion
- 2009-11-13
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.